Buchumschlag

Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis

Background - Antibodies to aquaporin-4 (AQP4-Ab) are found in 60-80% of patients with neuromyelitis optica (NMO), a severely disabling inflammatory CNS disorder of putative autoimmune aetiology, which predominantly affects the optic nerves and spinal cord. - Objective - To assess the frequency of AQ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jarius, Sven (VerfasserIn) , Frederikson, Jette (VerfasserIn) , Waters, Patrick (VerfasserIn) , Paul, Friedemann (VerfasserIn) , Akman-Demir, Gulsen (VerfasserIn) , Marignier, Romain (VerfasserIn) , Franciotta, Diego (VerfasserIn) , Ruprecht, Klemens (VerfasserIn) , Kuenz, Bettina (VerfasserIn) , Rommer, Paulus (VerfasserIn) , Kristoferitsch, Wolfgang (VerfasserIn) , Wildemann, Brigitte (VerfasserIn) , Vincent, Angela (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: [15 November 2010]
In: Journal of the neurological sciences
Year: 2010, Jahrgang: 298, Heft: 1/2, Pages: 158-162
ISSN:1878-5883
DOI:10.1016/j.jns.2010.07.011
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jns.2010.07.011
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0022510X10003345
Volltext
Verfasserangaben:Sven Jarius, Jette Frederikson, Patrick Waters, Friedemann Paul, Gulsen Akman-Demir, Romain Marignier, Diego Franciotta, Klemens Ruprecht, Bettina Kuenz, Paulus Rommer, Wolfgang Kristoferitsch, Brigitte Wildemann, Angela Vincent
Beschreibung
Zusammenfassung:Background - Antibodies to aquaporin-4 (AQP4-Ab) are found in 60-80% of patients with neuromyelitis optica (NMO), a severely disabling inflammatory CNS disorder of putative autoimmune aetiology, which predominantly affects the optic nerves and spinal cord. - Objective - To assess the frequency of AQP4-Ab in patients with optic neuritis (ON), and to investigate the prognostic implications of AQP4-Ab seropositivity in such patients. - Patients and methods - AQP4-Ab serum levels were determined in 224 individuals from Austria, Denmark, France, Germany, Italy, and Turkey using a newly developed fluorescence immunoprecipitation assay employing recombinant human AQP4. - Results - AQP4-Ab were detectable in 8/139 (5.8%) patients with acute monosymptomatic optic neuritis (AMON) and in 10/17 (58.8%) patients with established NMO and a last relapse of acute ON (NMO/ON), but not in 32 patients with multiple sclerosis or in 36 healthy controls. At last examination, 4/8 (50%) seropositive AMON patients had met the criteria for NMO but 0/128 seronegative AMON patients. Disease severity differed significantly between seropositive and seronegative AMON. Complete bilateral or unilateral blindness occurred in six AQP4-Ab positive patients, but only in one AQP4-Ab negative patient. AQP4-Ab levels did not vary between seropositive AMON and NMO/ON and did not correlate with disease severity. Female gender, a relapsing course, and concomitant autoimmunity were associated with AQP4-Ab seropositive status and risk of developing NMO. - Conclusion - AQP4-Ab is relatively rare among patients with AMON, but if present it predicts a high rate of conversion to NMO within one year.
Beschreibung:Gesehen am 26.07.2023
Beschreibung:Online Resource
ISSN:1878-5883
DOI:10.1016/j.jns.2010.07.011

Ähnliche Einträge